MedTrace Logo

AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects

NCT00769899 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2009-03-18

No results posted yet for this study

Summary

This is a Phase I randomized double-blind, placebo-controlled, single centre study to assess the safety, tolerability and pharmacokinetics of AZD7325 following single ascending dose administration to healthy male Japanese volunteers.

Conditions

  • Healthy Volunteer

Interventions

DRUG

AZD7325

Capsule for oral, single dose

DRUG

Placebo

Placebo capsule for oral, single dose

Sponsors & Collaborators

Principal Investigators

  • Mark Yen, MD · California Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00769899 on ClinicalTrials.gov